CORONA Remedies Limited (NSE:CORONA)
India
· Delayed Price · Currency is INR 1,685.20
-1.10 (-0.07%)
At close: Apr 28, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 103.07 billion as of April 29, 2026.
Market Cap
103.07B
Enterprise Value
103.15B
Revenue
13.44B
Ranking
n/a
PE Ratio
60.14
Stock Price
1,685.20
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 103.07B, an increase of 17.16%. That is a compound annual growth rate of 53.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 103.07B | 21.68% |
| Dec 31, 2025 | 84.70B | -3.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 91.13B |
| Procter & Gamble Health | 85.93B |
| Caplin Point Laboratories | 134.04B |
| Sanofi India | 79.07B |
| Jubilant Pharmova | 151.24B |
| Rubicon Research | 157.95B |
| Granules India | 172.24B |
| FDC Limited | 59.40B |